Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., ... & Ren, G. (2018). Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes & Diseases, 5(2), 77–106.

Ward, C., Meehan, J., Mullen, P., Supuran, C., Dixon, J. M., Thomas, J. S., ... & Langdon, S. P. (2015). Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models. Oncotarget, 6(28), 24856.

Alwan, N. A. (2016). Breast cancer among Iraqi women: Preliminary findings from a regional comparative Breast Cancer Research Project. Journal of Global Oncology, 2(5), 255.

Tremblay, D., Latreille, J., Bilodeau, K., Samson, A., Roy, L., L’Italien, M. F., & Mimeault, C. (2016). Improving the transition from oncology to primary care teams: A case for shared leadership. Journal of Oncology Practice, 12(11), 1012–1019.

Chabner, B. A., & Roberts Jr, T. G. (2005). Chemotherapy and the war on cancer. Nature Reviews Cancer, 5(1), 65–72.

Weaver, B. A. (2014). How Taxol/paclitaxel kills cancer cells. Molecular Biology of the Cell, 25(18), 2677–2681.

Xiao, Q., Zhou, Y., & Lauschke, V. M. (2020). Impact of variants in ATP-binding cassette transporters on breast cancer treatment. Pharmacogenomics, 21(18), 1299–1310.

Ozen F, Silan C, Uludag A, Candan F, Silan F, Ozdemir S, Atik S, Ozdemir O. Association between ABCB1 (MDR1) gene 3435 C> T polymorphism and colchicine unresponsiveness of FMF patients. Renal failure. 2011 Oct 1;33(9):899-903.

Chaithanya SM, Annapurna MM. Stability indicating RP-UPLC method for the simultaneous determination of Atorvastatin and Amlodipine. Research Journal of Pharmacy and Technology. 2019;12(10):4867-72.

Nelson, H. D., Zakher, B., Cantor, A., Fu, R., Griffin, J., O’Meara, E. S., ... & Miglioretti, D. L. (2012). Risk factors for breast cancer for women aged 40 to 49 years: A systematic review and meta-analysis. Annals of Internal Medicine, 156(9), 635–648.

Miranda-Galvis, M., Loveless, R., Kowalski, L. P., & Teng, Y. (2021). Impacts of environmental factors on head and neck cancer pathogenesis and progression. Cells, 10(2), 389.

Greenup, R. A., Rushing, C., Fish, L., Campbell, B. M., Tolnitch, L., Hyslop, T., ... & Hwang, E. S. (2019). Financial costs and burden related to decisions for breast cancer surgery. Journal of Oncology Practice, 15(8), e666–e676.

Berhili, S., Kadiri, S., Bouziane, A., Aissa, A., Marnouche, E., Ogandaga, E., ... & Benjaafar, N. (2017). Associated factors with psychological distress in Moroccan breast cancer patients: A cross-sectional study. The Breast, 31, 26–33.

Helms, E., Onate, M. K., & Sherman, M. H. (2020). Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment. Cancer Discovery, 10(5), 648–656.

Duma, N., Santana-Davila, R., & Molina, J. R. (2019, August). Non–small cell lung cancer: epidemiology, screening, diagnosis, and treatment. In Mayo Clinic Proceedings (Vol. 94, No. 8, pp. 1623-1640). Elsevier.

Kryukov, A. V., Sychev, D. A., Andreev, D. A., Ryzhikova, K. A., Grishina, E. A., Ryabova, A. V., ... & Bochkov, P. O. (2018). Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke. Pharmacogenomics and Personalized Medicine, 43–49.

Barliana, M. I., Kusuma, A. S. W., Insani, W. N., Alfian, S. D., Diantini, A., Mutakin, M., ... & Abdulah, R. (2021). Genetic variation of ABCB1 (rs1128503, rs1045642) and CYP2E1 rs3813867 with the duration of tuberculosis therapy: A pilot study among tuberculosis patients in Indonesia. BMC Research Notes, 14(1), 1–7.

Su, S. C., Lin, C. W., Ju, P. C., Chang, L. C., Chuang, C. Y., Liu, Y. F., ... & Yang, S. F. (2021). Association of linc00673 genetic variants with progression of oral cancer. Journal of Personalized Medicine, 11(6), 468.